Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.

Tsiambas, Evangelos

Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19. [electronic resource] - Pathology oncology research : POR 10 2020 - 2823-2825 p. digital

Publication Type: Letter

1532-2807

10.1007/s12253-020-00810-6 doi


Angiotensin-Converting Enzyme 2
Betacoronavirus--genetics
Biomarkers
COVID-19
Coronavirus Infections--complications
Hematologic Neoplasms--complications
Humans
Immunocompromised Host
Pandemics
Peptidyl-Dipeptidase A--genetics
Pneumonia, Viral--complications
Polymorphism, Single Nucleotide
SARS-CoV-2